Mitchall G. Clark
Consigliere Generale presso AADI BIOSCIENCE, INC.
Profilo
Mitchall G.
Clark is a Senior VP-Regulatory Affairs & Quality Assurance at Aadi Bioscience, Inc. He previously held positions as Senior Director-Regulatory Affairs at Faulding, Inc. and American Bioscience, Inc., Vice President-Regulatory Affairs at APP Pharmaceuticals, Inc., Senior Vice President-Global Regulatory Affairs at Abraxis BioScience, Inc., Senior Vice President-Regulatory Affairs at Celgene Corp., NantWorks LLC, and Abraxis BioScience, Inc., Senior Vice President-Regulatory Affairs & Quality at NantPharma LLC, and Chief Regulatory & Quality Assurance Officer at Atara Biotherapeutics, Inc. He also worked as a Principal at Lindum Pharmaceutical Services Corp.
Mr. Clark received an undergraduate degree from The University of Nottingham.
Posizioni attive di Mitchall G. Clark
Società | Posizione | Inizio |
---|---|---|
AADI BIOSCIENCE, INC. | Consigliere Generale | 01/08/2018 |
Precedenti posizioni note di Mitchall G. Clark
Società | Posizione | Fine |
---|---|---|
Lindum Pharmaceutical Services Corp. | Corporate Officer/Principal | 01/03/2014 |
NantPharma LLC
NantPharma LLC Pharmaceuticals: MajorHealth Technology Part of NantWorks LLC, NantPharma LLC is a company that manufactures injectable pharmaceutical products. The company is based in Lincolnshire, IL. | Consigliere Generale | 01/06/2013 |
CELGENE | Consigliere Generale | 01/06/2011 |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Consigliere Generale | 01/11/2007 |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Consigliere Generale | 01/04/2006 |
Formazione di Mitchall G. Clark
The University of Nottingham | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
AADI BIOSCIENCE, INC. | Health Technology |
ATARA BIOTHERAPEUTICS, INC. | Health Technology |
Aziende private | 10 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Faulding, Inc. | Health Technology |
American Bioscience, Inc. | Health Technology |
DNIB Unwind, Inc.
DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
APP Pharmaceuticals, Inc.
APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Health Technology |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Health Technology |
NantWorks LLC
NantWorks LLC Information Technology ServicesTechnology Services NantWorks LLC develops technology based semiconductor and advanced networks for healthcare improvements. Its solution is for life threatening diseases such as cancer, infectious diseases and Alzheimer’s. The company was founded by Patrick Soon-Shiong in September 2011 and is headquartered in Culver City, CA. | Technology Services |
NantPharma LLC
NantPharma LLC Pharmaceuticals: MajorHealth Technology Part of NantWorks LLC, NantPharma LLC is a company that manufactures injectable pharmaceutical products. The company is based in Lincolnshire, IL. | Health Technology |
Lindum Pharmaceutical Services Corp. |
- Borsa valori
- Insiders
- Mitchall G. Clark